Publisher： Bentham Science Publishers
E-ISSN： 1873-4316|14|7|669-682
ISSN： 1389-2010
Source： Current Pharmaceutical Biotechnology, Vol.14, Iss.7, 2013-10, pp. : 669-682
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Improved knowledge and understanding of key aspects of cancer has led to the development of novel cancer therapeutics acting through complex pathways and mode of actions. The success of these novel cancer therapeutics is often difficult to predict using standard response criteria based on anatomic changes. Monitoring response to cancer therapy at molecular level using Positron Emission Tomography (PET) has gained popularity in recent years. PET allows longitudinal assessment of specific biological processes rather than just changes in anatomic changes in tumor size. In this review, we provide an overview on application for PET imaging to monitor cancer therapy with emphases on PET of tumor metabolism, cell proliferation, angiogenesis, hypoxia and receptor dynamics.
Related content
Access to resources
Recommend
PET Imaging for Gene & Cell Therapy
Current Gene Therapy, Vol. 12, Iss. 1, 2012-02 ,pp. :
Development of PET Probes for Cancer Imaging
Current Topics in Medicinal Chemistry, Vol. 15, Iss. 8, 2015-04 ,pp. :
18F-fluorodeoxyglucose PET/CT in cancer imaging
By Kayani Irfan Groves Ashley M
Clinical Medicine, Vol. 6, Iss. 3, 2006-05 ,pp. :
Can PET Imaging Facilitate Optimization of Cancer Therapies?
Current Pharmaceutical Design, Vol. 18, Iss. 18, 2012-06 ,pp. :